Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XBI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

XBI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

XBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Vanzeyst, Albert Wilhelmus10% Security Holder 2015-09-03Sell10,000$0.8924410.11view
Vanzeyst, Albert Wilhelmus10% Security Holder 2015-09-03Sell6,500$0.924137.78view
Noone, Patrick DonnellDirector 2015-09-03Buy1,200$4.265020.66view
MacNeil, Glenn GarrySenior Officer 2015-09-03Buy2,000$37171.33view
MacLeod, CeilidhSenior Officer 2015-09-03Sell3,000$2.957294.58view
Newman, G. MichaelDirector 2015-09-03Buy18,000$0.06363466.67view
Kovacevic, John GianniDirector, Senior Officer 2015-09-03Buy50,000$0.04545250view
Kovacevic, John GianniDirector, Senior Officer 2015-09-03Buy75,000$0.04545250view
Durst, George10% Security Holder 2015-09-03Buy40,000$0.021090600view
Corman, Francis DaleSenior Officer 2015-09-03Buy86,000$0.03727033.33view

Quarterly/Annual Reports about XBI:

    News about XBI:

    Articles On GuruFocus.com
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    State Street Splits Coming For Retail, Biotech ETFs Sep 04 2015
    Incyte Helps XBI to Outperform IBB’s Top 10 Sep 04 2015
    Benchmark Indexes Continue to Outperform IBB and XBI Sep 04 2015
    XBI Pharmaceutical Valuation Rises on Strong Small-Cap Performance Sep 02 2015
    Acadia, Neurocrine, Dyax, and Opko Trade Below 50-Day Moving Average Sep 02 2015
    ICPT and XON Put Pressure on XBI’s Biotechnology Sector Sep 02 2015
    Why Did Intrexon Fall by 14.40%? Sep 02 2015
    Analyzing Incyte: What Kind of Company Is It? Sep 02 2015
    Incyte Was a Star Performer from August 10–17, 2015 Sep 01 2015
    State Street Global Advisors Announces ETF Share Splits Sep 01 2015
    XBI Remains Flat as of August 17, 2015 Aug 31 2015
    How Does Novavax Compare to Its Competitors? Aug 31 2015
    4 ETFs That Finished the Wild Week in Green Aug 31 2015
    What Are IBB and XBI’s Valuations? Aug 25 2015
    Biotech Stocks Recover From Early-Morning Flash Crash Aug 24 2015
    IBB Outperforms XBI: Top 10 Mid-Cap Stocks Aug 21 2015
    The Dow's very, very bad day Aug 20 2015
    IBB Outperforms XBI: Top 10 Large-Cap Stocks Aug 20 2015
    IBB and XBI Underperformed the Benchmark Indexes Aug 20 2015
    Fear and loathing on trading desks Aug 20 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)